BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$65.88
-3.35 (-4.84%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+27.92%
YTD
-15.79%
Open$69.52
Previous Close$69.23
Day High$70.01
Day Low$64.90
52W High$93.42
52W Low$48.78
Volume—
Avg Volume2.48M
Market Cap13.16B
P/E Ratio—
EPS$-3.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.38
Below
SMA 200
$56.39
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
+188.5% upside
Current
$65.88
$65.88
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 517.85M | 277.97M | 2.34B |
| Net Income | -747,716,947 | -361,215,916 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -556,076,205 | -283,560,061 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |